UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seeding variability of different alpha synuclein strains in synucleinopathies

Annals of neurology, 2019-05, Vol.85 (5), p.691-703

2019

Volltextzugriff (PDF)

Validation of Plasma Neurofilament Light Chain as a Marker for α‐Synucleinopathies

Movement disorders, 2021-11, Vol.36 (11), p.2701-2703

2021

Volltextzugriff (PDF)

A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease

Alzheimer's & dementia, 2020-10, Vol.16 (10), p.1438-1447

2020

Volltextzugriff (PDF)

Plasma YKL-40 in the spectrum of neurodegenerative dementia

Journal of neuroinflammation, 2019-07, Vol.16 (1), p.145-145, Article 145

2019

Volltextzugriff (PDF)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis

Neural regeneration research, 2020-05, Vol.15 (5), p.861-862

2020

Volltextzugriff (PDF)

The Interplay between Alpha-Synuclein Clearance and Spreading

Biomolecules, 2015-04, Vol.5 (2), p.435-471

2015

Volltextzugriff (PDF)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies

Frontiers in aging neuroscience, 2021-09, Vol.13, p.717930-717930

2021

Volltextzugriff (PDF)

Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease

Journal of clinical neuroscience, 2019-02, Vol.60, p.124-127

2019

Volltextzugriff (PDF)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's disease

Alzheimer's research & therapy, 2023-06, Vol.15 (1), p.116-116, Article 116

2023

Volltextzugriff (PDF)

Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies

Expert review of molecular diagnostics, 2017-10, Vol.17 (10), p.897-904

2017

Volltextzugriff (PDF)

Amyloid-like protein inclusions in tobacco transgenic plants

PloS one, 2010-10, Vol.5 (10), p.e13625-e13625

2010

Volltextzugriff (PDF)

Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies

Journal of neurochemistry, 2016-10, Vol.139 (S1), p.240-255

2016

Volltextzugriff (PDF)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis

Frontiers in bioengineering and biotechnology, 2020-11, Vol.8, p.586890-586890

2020

Volltextzugriff (PDF)

Yeast prions form infectious amyloid inclusion bodies in bacteria

Microbial cell factories, 2012-06, Vol.11 (1), p.89-89, Article 89

2012

Volltextzugriff (PDF)

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors

Microbial cell factories, 2012-05, Vol.11 (1), p.55-55, Article 55

2012

Volltextzugriff (PDF)

Plasma neurofilament light chain as a biomarker for fatal familial insomnia

European journal of neurology, 2022-06, Vol.29 (6), p.1841-1846

2022

Volltextzugriff (PDF)

Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3

Journal of neurology, 2020-02, Vol.267 (2), p.543-550

2020

Volltextzugriff (PDF)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2018, Vol.10 (1), p.461-470

2018

Volltextzugriff (PDF)

Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease

Molecular neurobiology, 2022-09, Vol.59 (9), p.1-9

2022

Volltextzugriff (PDF)

The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity

Human molecular genetics, 2014-12, Vol.23 (25), p.6732-6745

2014

Volltextzugriff (PDF)

Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Movement disorders, 2022-01, Vol.37 (1), p.39-51

2022

Volltextzugriff (PDF)

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

Nature communications, 2020-01, Vol.11 (1), p.619-619, Article 619

2020

Volltextzugriff (PDF)

Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

Molecular neurobiology, 2018-11, Vol.55 (11), p.8586-8591

2018

Volltextzugriff (PDF)

Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency

Molecular neurobiology, 2020-04, Vol.57 (4), p.1863-1874

2020

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(61)
Buchkapitel
(2)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seeding variability of different alpha synuclein strains in synucleinopathies

Validation of Plasma Neurofilament Light Chain as a Marker for α‐Synucleinopathies

A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease

Plasma YKL-40 in the spectrum of neurodegenerative dementia

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis

The Interplay between Alpha-Synuclein Clearance and Spreading

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies

Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's disease

Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies

Amyloid-like protein inclusions in tobacco transgenic plants

Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis

Yeast prions form infectious amyloid inclusion bodies in bacteria

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors

Plasma neurofilament light chain as a biomarker for fatal familial insomnia

Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease

The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity

Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency

Suchergebnisse filtern